Estimates Revisions Lineage Cell Therapeutics, Inc.
Stocks
LCTX
US53566P1093
Biotechnology & Medical Research
|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.335 USD | +4.30% |
|
+5.56% | -20.36% |
| 08:16pm | Lineage Cell Therapeutics, Inc.(NYSEAM:LCTX) added to Russell 2500 Growth Benchmark | CI |
| 11:45am | Lineage Cell Therapeutics, Inc.(NYSEAM:LCTX) added to Russell 2000 Growth Benchmark | CI |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| - | |||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
- Stock Market
- Stocks
- LCTX Stock
- Consensus Lineage Cell Therapeutics, Inc.
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
